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The biologic classification of pneumococci, according to  Dochez 
and  Gillespie,  1  divides  these  organisms  into  four  main  groups. 
These  groups  represent  well  defined types  which  are  distinct  and 
readily differentiated ,by immunological reactions.  In previous com- 
munications  2 the varieties of pneumococci, their relation to disease, 
and  their  significance  in  problems  of  specific  therapy  have  been 
discussed in detail.  The present work is  confined to  a  study of a 
limited number  of  strains  of  pneumococci which,  because  of  cer- 
tain serological reactions, are closely allied to the second group, and 
appear to represent distinct subgroups of Pneumococcus Type II. 
In classifying pneumococci by serological methods, agglutination 
and protection experiments have been employed.  Agglutination of 
typical pneumococci of the second group in an immune serum of the 
homologous type is prompt and characteristic.  There is occasionally 
encountered, however, an organism with which the agglutination re- 
action in Antipneumococcus Serum II is incomplete and less prornpt, 
often being delayed several hours.  The occurrence of strains show- 
ing these peculiarities has been  frequent enough to direct attention 
to  them,  since  in  the  presence  of  a  positive,  ,but  atypical  agglu- 
tination, some confusion may arise in diagnosis.  Theoretically, too, 
it is of interest to determine, if possible, whether or not these varia- 
tions in agglutinability indicate essential biologic differences. 
The  facts  presented  are  a  result  of  a  study  of  ten  strains  of 
pneumococci, all of which agglutinated in Antipneumocoecus Serum 
II,  atypically  as  described  above.  Cross-immunity  reactions  and 
1 Dochez,  A. R.,  and Gillespie, L. J., Your.  Am. Med. Assn.,  1913, |Xi,  727. 
Cole,  Rufus,  Arch.  Int.  Med.,  1914, xiv,  56;  New  York  Med.  Your.,  1915, 
ci, I, 59.  Dochez, A. R., and Avery, O. T., Your.  Exper. Med.,  1915, xxi,  114. 
804 Oswald T.  Avery.  805 
absorption tests  indicate that these organisms possess  characteristic 
group relationships among themselves and a common antigenic rela- 
tion to the original and typical Type II pneumococcus. 
Description  of  Cultures.--Ten  strains  of  pneumococci  were 
chosen, five of which were isolated  from disease and five from the 
sputum  of normal individuals.  Table  I  gives  the  source and  cul- 
ture designation of 'Vhe S~l:ains studied. 
TABLE i. 
Pneumococcus.  Source.  Obtained from  Remarks. 
J 
L 
M 
Jn 
W 
As 
Ar 
FCB 
S  I3 
H 
Acute maxillary antrum 
lobar pneumonia 
Primary pneumonia (child) 
Normal indi-idual 
,1  6* 
Diabetic patient 
Pus 
Lung puncture 
Blood 
Sputum 
Lung puncture 
Sputum 
Recovery. 
Septicemia, fatal. 
Recovery. 
Fatal. 
No infection. 
These ten strains possess the common characteristic of partial ag- 
glutination in antipneumococcus serum of Type II.  Culturally and 
biologically they present all the usual characters of typical pneumo- 
cocci:  such  as  inulin  fermentation,  bile  solubility,  and  more  or 
less  distinct  capsule  formation.  Their  virulence on  isolation  was 
distinctly lower than that of the typical Type II organism. 
Agglutination as illustrated in Table II establishes a definite rela- 
tionship between .the strains studied and the type organism of Pneu- 
mococcus Group II.  The reaction of all ten strains in  Serum II is 
distinct,  but  never  as  prompt  or  complete  as  in  ~he  case  of  the 
typical Group II organism.  With all typical Type II pneumococci 
the agglutination begins almost immediately and is  complete in half 
an hour, while the reaction of these ten strains is always delayed and 
often incomplete at the end of the period of observation.  It is  fur- 
ther  evident that 'these minor agglutinins  tend  to  disappear  in  the 
higher dilution and are completely absent in dilution of  I  to 80,  at 
which titer the reaction of the type organism s.till persists. 
This variation in agglutination was at firsi attributed to the pos- 
sibility  that  there  might  exist,  among  pneumococci  of  Group  II, 806  Biologic Classification of Pneumococci. 
EXPERIMENTAL. 
Agglutination Experiments. 
TABLE  II. 
Determination  of  the  Titer  of  Agglutination  of  Strains  in  Antipneumococcus 
Serum II,  Using Antipneumococcus  Serum I  and Normal Horse Serum 
(N)  as  ContrOls. 
Dilution.  i:i  I  I  i :io  1:2o  i  i:4o  i :8o 
I 
S  ....  N  '  ]  i  II  N  i  I  ]  'II  N  I  1I  I  X  '  I  It  !  N  I  n 
L6.  !  -I++ 
M  S TM  i  --  :-[--]-  +'31- 
Ar9 5  I-----++  ++  i  +  i 
j  78  j  _  ++j  ++l  i 
W  59  :  -  ,++  ,l++ 
FCB95  ~  +  I++ 
S  I3  I23  +q-i++'  q_+  I 
H73  +  1;;  +  t+  t  +  II 4611 
,.,-  +  +  + 
The  reactions  were  read  after  2  hrs.  at 37 °  C.  and over  night  on  ice. 
The  numerals  following  the  culture  indicate  the  animal  passage;  the  expo- 
nent indicates  the number  of  generations  removed  from  the  last  passage. 
TABLE  III. 
The  Effect  of  Increased  Virulence  upon  the  Agglutinability  of  the  Atypical 
Group II Pneumococcus in Antipneumococcus Serum II. 
Antlpneumococcus Serum  II. 
Dilution. 
i :  io  z  :2o  i:4  °  1:8o 
Pneumoeoccus 
M  0 9  ++  ++  _+  -- 
M  511  ++  ++  +  -- 
L  0  9  ++  ++  --  -- 
L  6 I1  ++  ++  _+  -- 
Jn  o  ~  +  ~  -  - 
Jn IO  a  +  +  +  -  - 
F  C  B  116  +  +  --  --  -- 
F  C  B  11  s  ++  --  --  -- 
II 4611  ++  -Jc+  ++  ++ 
The  numerals  after  the  culture  indicate  number  of  mouse  passages. 
The  exponent  indicates  the  number  of  generations  removed  from  the  last 
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strains of poor agglutinability, analogous to similar conditions among 
other  bacterial  groups.  It  was  also  thought  that,  since  these  or- 
ganisms  were  of  lower virulence  than  the  type organism,  :this  fact 
might  bear  some  relation  to  their  agglutinability.  Agglutination 
tests  were  carried  out  wifh  certain  atypical  strains,  the  virulence 
of which had been enhanced by repeated animal passage.  The effect 
of the animal passage on the agglutination titer was then determined. 
Four  strains  were  chosen,  Che  virulence  of  which  was  raised  by 
mouse passage until it had a,ttained a point comparable to that of the 
typical  Type  II  pneumococcus,  with  a  minimum  le[hal  dose  of 
o.oooooi cc. of broth culture. 
It is evident from Table III that enhancing  the virulence of these 
strains did not affect their agglutinability.  The variations in agglu- 
tinations  between these  strains  and  the  type pneumococcus  appear 
to be not merely differences in agglutinability,  but suggest rather the 
possibility that  actual  differences  in  agglutinogenic  properties  may 
characterize these organisms.  To determine this a univalent immune 
serum  was  prepared  by  immunization  of  rabbits  to  eaCh  of  the 
ten strains. 
Agglutination  by Immune Rabbit  Sera  of  the  Ten Strains  of 
Atypical Group II Pneurnococci and the Results  Obtained 
by  Cross-Agglutination. 
TABLE IV. 
Agglutination of the  Ten Strains  by Homologous Sera and the Effect  of Such 
Sera on Stock  Cultures of Pneumococcus of Type II. 
Immune rabbit  sera. 
Sera. 
Culture. 
I  :I 
I  :IO 
I  :20 
I  :40 
As 
~+  - 
++ 
++ 
Ar  S* 3  F  CB  ,  H 
Ar  T  II  S~3-].  II  FCB  ]  II  H  el 
+)---  -  -_  -:+  ++ 
++  i  +++  ~i  -  ++  +  ~  ++  ++1 
Sera.  L  J 
Culture.  L  II  J 
++  -  ++ 
++  ++ 
++  ++ 
++  ++ 
I  :I 
I  :IjO 
I  :20 
x  :4  o 
Jn 
II  Jn 
-  ;-; 
++ 
++ 
++ 
n  w 
-  ;-+ 
++ 
++ 
++ 
W  M 
II  M  .  n 
++ 808  Biologic  Classification of Pneumococci. 
Table IV shows that the rabbit immune atypical sera each agglu- 
tinated  strongly  the  homologous  strain  of  pneumococcus,  but  that 
none  of these sera  had  any effect on the  type culture  of  Group II. 
This failure of the antisera of the ten strains to agglutinate the Type 
II  pneumococcus  shows  differences  in  the  antigenic  properties  of 
these organisms  and  is in striking  contrast to the  positive reactions 
of  agglutination  with  these  same  strains  by  Antipneumococcus 
Serum  II  (Table  II).  This  failure  of  reversibility  of  the  agglu- 
tination  reaction  would seem,  therefore,  to be due to  actual  differ- 
ences in the agglutinogenic groups of these various organisms. 
TABLE V. 
Cross-Agglutlnation. 
Immune sera.  As  ] 
I 
SI3  --  I 
FCB 
Ji 
J  ++ 
W  [-- 
M  i+ 
tt  i  -- 
Normal  rabbit!  -- 
II  ] q- 
Pneumococcus cultures. 
Arm____ '-- 
++ 
++ 
++ 
+ 
++ 
++ 
+-+ 
++ 
j  Jn 
-  ++ 
+  - 
++  +-÷  +-+ 
+  ++ 
W  M 
-  ++ 
+ 
++  - 
- 
++  -  _ 
_  _  ++ 
++  ++  ++ 
H  II 
++ 
Table  V  reveals  the  striking  fact  that  in  a  series  of  organisms 
wholly contained within  Group II  certain  separate relationships  are 
demonstrable.  An  analysis  of  this  table  indicates  clearly  the  ex- 
istence  of three  distinct  groups  which  appear  to  represent  subdivi- 
sions of the main Group II, in the antiserum of which all members of 
each of these subdivisions are agglutinated.  For purposes  of con- 
venience  these  subdivisions  will be referred  to  as  Subgroups  II  A, 
II  B, and II X, and are shown more clearly in Table VI. 
Subgroup II  A  consists of four strains,  the  immune reactions  of 
which are specific within the group, being identical with those of all 
other strains  of the group, but bearing no relation  to those of Sub- 
groups  II  B, or  II  X.  Similarly,  Subgroup  II  B  consists  of three 
other  strains  characterized  by the  possession  of  specific  immunity Oswald  T.  Avery.  809 
TABLE VI. 
Subgroup II A. 
Pneumococcus  cultures. 
Immune sera. 
As  Jn  M  lI 
As  -I-+  -t- -t-  -1-+  +-b  -- 
L  ++  ++  ++  ++  -- 
Jn  +-I-  ++  ++  +-b  - 
M  ++  +  +  +  -- 
II  q-  --l- q-  q-- --k  --k --l--  -1--+ 
Subgroup IIB. 
Pneumococcus  cultures, 
Immune sera, 
Ar  W  II 
Ar 
J 
w 
II 
++ 
++ 
++ 
+ 
+ 
++ 
+ 
+ 
+ 
++ 
++ 
++  ++ 
Subgroup II X. 
Pneumococcus  cultures, 
Immune  sera. 
F  C  E  S  ~3  ]  H  II 
I 
FCB 
S I3 
H 
II 
++ 
+ 
_  i  _ 
++ 
-  ++ 
++  i  ++  ++ 
reactions,  identical  for members  of  this  subgroup  alone.  The  re- 
maining three strains have been placed in Subgroup II X  which, like 
the larger Group IV of the original biologic classification, is peculiar 
in that  it seems to consist of a  heterogeneous series of independent 
strains which do not cross in their immunity reactions with members 
of  the  other  two  subgroups  or  with  each  other.  All,  however, 
possess the common character of atypical agglutination in Antipneu- 
mococcus  Serum  II.  This  subgroup,  like  its  prototype Group  IV, 
seems to be infinitely variable, and to be characterized by the absence 
of cross-immunity reactions and by lower virulence. 
Protection Experiments.--The  protection of  animals  against  in- 
fection is generally conceded to be one of the mosec specific of immun- 
ological reactions and hence one of the most satisfactory methods of 
classification.  White  mice  were  given  intraperitoneally  graduated 
doses of pneumococci and  at the same time a  fixed quantity of im- 
mune serum.  All animals except the virulence controls received 0.2 810  Biologic  Classification of Pneumococci. 
cc.  of immune serum intraperitoneally.  This  quantity of  Immune 
Serum II as  a  rule protects mice against  o.oI  cc.  of broth  culture 
of the homologous organism which, given alone, kills mice regularly 
in doses of o.oooooI  cc.  All animals surviving for five days were 
considered effectively prolected. 
In experimental pneumococcal infection the specificity of the pro- 
tective power of an immune serum is evident only when the culture 
employed is fully virulent.  Of the ten strains of pneum'ococci it was 
found  possible  'to  raise  the  virulence of  seven  by animal  passage. 
The virulence of the .other three strains could not be increased suffi- 
ciently for use in protection experiments, although they were passed 
successively through  I I,  I4,  and  I8  animals,  respectively.  They 
were even then of such low virulence that it was  impossible to kill 
mice with  the  moderate doses  necessary for  the  successful carry- 
ing out of the test.  Of these three strains,  two bel,  onged to  Sub- 
group II X  and one to Subgroup II A. 
Further Evidence of the Specificity  of Group Relationships  by Pro- 
tection  Experiments. 
TABLE  VII. 
Protective Action of Antipneumoeoceus Serum H. 
The Relation between the Specificity of the Protective Action  of Immune Serum 
and  the  Virulence  of the Infecting  Organism. 
Pneumococcus L  (Subgroup  II A)  after  One  Animal Passage. 
Pneumococcus  LI 1.  Virulence controls.  Serum  II.  Serum  I.  Normal serum. 
c6. 
o.oI  S.*  D. 96  S. 
0.00I  D.  72  "  S.  " 
o.oooI  S.  "  D.  96 
O,OOO01  *'  "  "  S. 
o.oooooz  D.  72  "  D. 96  D. 96 
Pneumococcus  L  (Subgroup  II  A)  after  Seven  Animal  Passages. 
Pneumococcus  L  71.  Virulence controls.  Serum  II,  Serum  I. 
cc. 
o.ox  S.  D.  i8 
O.OOI 
o.oooi  D. 36  ....  ~4 
o.ooooI  "  "  "  36 
O.OO000I 
* In the tables D.  stands for died;  S.  for  survived.  The figures represent the 
number  of  hours  before the  death  of  the animal. Oswald  T.  Avery.  811 
Table VII shows that after  increasing the virulence of .pneumo- 
coccus L  (Subgroup II A)  to a  degree sufficient to apply the test, 
definite protection was afforded by stock Antipneumococcus Serum 
II against IO,OOO times the minimal lethal dose of culture.  The odd 
survivals and non-specific reactions with the same strain before its 
virulence was  raised  by animal passage  is  evidence of  the  futility 
of attempting specific reactions of a protective n'ature with avirulent 
organisms.  That  this phenomenon does not represent a  reversion 
to type brought about by animal passage is evidenced by l:he fact that 
the antigenic properties of these organisms remained unaffected by 
such treatment.  Of the seven strains,  the virulence of which was 
increased by mouse passage, Antipneumococcus Serum Type II pro- 
tected against six,  three of which belonged to Subgroup II A  and 
three to Subgroup IIB.  The seventh strain, an organism of Sub- 
group II X, although made equally virulent by nine mouse passages, 
was not protected against 'by immune serum of Type II. 
Cross-Protection Tests with Homologous and Heterologous Sera of 
the  Three Subgroups  of Pneumocoecus H. 
TABLE VIII. 
Protective Action  of Sera of Subgroup II A  against a Pneumococcus of  the 
Same Group, and Failure of Sera of Subgroups H  B  and II X  to 
Protect against the Same  Organism. 
Pneumococcus  Immune  sera. 
Subgroup II a.  Subgroup II A.  Subgroup lIB.  Subgroup II X. 
Jn 91 
gO. 
O.OI 
O.OOI 
O.O00I 
O.O000I 
O.O00001 
Jn  _[  g 
D.  72  ]  S. 
W 
D.  I8 
~d  ,4 
iJ  *J 
FCB 
D.  18 
24 
Antipneumo- 
coccus 
Type II. 
D. 96 
S. 
J6 
6~ 
Virulence 
controls. 
D.  I8 
"  24 
Tables VIII and IX demonstrate that an immune serum of Sub- 
groups II A and IIB protects against any organism of the homolog- 
ous subgroup, but fails to protect against any strain of the other two 
subgroups.  Table X  emphasizes the individual character of organ- 812  Biologic  Classification  of  Pneumococci. 
TABLE  IX. 
Protective Action of Sera of Subgroup II B against a Pneumococcus of the Same 
Subgroup  and Failure  of Sera of Subgroups  II A  and II X  to  Protect 
against the Same  Organism. 
Pneumococcus 
Subgroup IIB. 
W  61 
CC. 
0,0I 
0.OOI 
O.OOOI 
0.O00OI 
0.00000I 
Subgroup II ]3,  :  SubgrouplII A. 
S.  i  " 
Immune sera. 
Subgroup II X.~ 
FCB 
D.  18 
~d  ,6 
Antipneumo- 
coccus 
Type II. 
D.  96 
S. 
d~ 
Virulence 
controls. 
D.  18 
TABLE  X. 
Protective Action  of Serum  of Subgroup  II X  against  the Homologous  Organ- 
isms Only  and Failure  of Sera  of Subgroups  II A  and  IIB  and  Anti- 
pneumococcus Serum II To  Protect against  the Same. 
Pneumococcus  Immune  sera. 
Subgroup  II X. 
Subgroup II X.  Subgroup II A.  Subgroup II B.  Antipneumo-  Virulence 
coccus  controls. 
F  C 13 II  1  F  C B  S  13  Jn  W  Type II. 
o.oI  D.  I8  D.  18  D.  I8  D.  18  D.  18 
0.001  S.  "  "  "  "  "  "  "  " 
O,OOOI  "  "  "  "  "  D.  18 
0,00001  **  "  22  "  '*  ** 
o.oooool  "  "  36  "  " 
TABLE  XI. 
Lack  of Protective Power of Immune  Sera  of Subgroups  II A, II B, and  If X 
against  Typical Pneumococcus II. 
Pneumococcus 
Type II. 
II 461 
cO. 
0.oi 
0,0oi 
0.000I 
0.000oi 
0.0000oi 
Immune ser~. 
SubgroUPjn II A.  .  SubgrOUPw  II B. 
D. 18  I  D. 18 
,,  66  ! 
Subgroup  IIX. 
FCB 
D. 18 
"  26 
Virulence con- 
trols. 
I).  I8 Oswald T. Avery.  813 
isms of Subgroup II X.  A  serum produced by immunization with 
any given strain of this type protects against that particular organism 
and against no other.  As previously noted, there is a complete lack 
of crossing in ~he immunity reactions of the individual members of 
Subgroup II X.  Table XI shows that in protective action, as in ag- 
glutination (Table IV), the immune sera of Subgroups II A, II B, 
and  II  X  have no effect on the typical pneumococcus of Type II. 
That  these  immunologic reactions  between  the  original  Type  II 
pneumococcus and  organisms  of the  subgroups  are  not  reversible 
seems  to  indicate  degrees  of  difference  in  antigenic  characters. 
While the serological specificity of the subgroups definitely separates 
one  from  the other,  nevertheless their  immune reactions  with  the 
antisera of the typical Type II organism indicate that they are all 
biologically related.  The correlation of these subgroups is  further 
proven by absorption tests. 
Absorption Experiments.--The phenomenon of specific absorp- 
tion of agglutinins from an immune serum by the homologous or- 
ganism was first described by Castellani.  3  This investigator found 
that  from a  polyvalent serum produced by immunization with two 
microorganisms of different species, the agglutinins  for either one 
could be  removed by  fractional  absorption  with  the  homologous 
strain, while in a serum thus exhausted, the antibodies for the second 
organism remained intact.  It  has  been shown also  that  in a  uni- 
valent serum against Bacillus typhosus not only are agglutinins pres- 
ent for that organism alone, but that in the same serum there also 
exist partial or minor agglutinins for bacilli  which are biologically 
similar, and which fall within the same general group.  Absorption 
of a  typhoid immune serum by Bacillus typhosus removes not only 
the agglutinins for that organism, but completely exhausts the serum 
of its minor antibodies for the closely allied organisms.  This reac- 
tion, however, is not reversible,  for removal of the partial  aggluti- 
nins by absorption with a member of the intermediary species leaves 
the antibodies for Bacillus typhosus practically undiminished.  The 
significance of this phenomenon in bacterial classification is obvious, 
and its applicability to the present study is evident in the following 
protocols. 
3 Castellani,  A.,  Ztschr. f. Hyg.  u. Infectionskrankh.,  1902  ,  xl,  I. 814  Biologic  Classification  o[ PneurnococcL 
Specificity  of Absorption  Reaction.  Absorption  of Antipneumococcus  Serum I 
ze4th Pneumococci of Groups I  and II. 
Technique.--Specific  absorption.  Antipneumococcus Serum I.  2 cc. of serum 
were  diluted with 3  cc.  of  salt solution.  To  the 5  cc.  of  diluted  serum  the  live, 
washed  bacterial  residue  of  15o  cc.  of  a  twenty-four  hour  broth  culture  of 
Pneumococcus I  was added,  allowed to  stand in contact over night in the ice box, 
then centrifuged,  the clear supernatant serum  pipetted  off,  and passed  through a 
Berkefeld filter, 
Non-specific  absorption.  Antipneumococcus  Serum  I  was  absorbed  with 
Pneumococcus  II.  The technique was  the same as  above. 
Control.  Antipneumococcus  Serum  I  diluted,  and,  without  the  addition  of 
any bacteria,  filtered by the  same  technique. 
TABLE  XII. 
Specific  and  Non-Specific  Absorption  of  Agglutinins  from  Antipneumococcus 
Serum I  by  Pneumococci  of  Groups I  and II. 
Agglutination. 
Culture pneumococcus, 
Group I. 
Antlpneumococcus Serum I. 
Specific absorption  Non-specific absorption  Control. 
with Pneumococcus I.  with Pneumococcus  II.  Serum unabsorbed. 
-  ++  ++ 
TABLE  XIII. 
Protective  Power of Antipneumococcus  Serum I  after Absorption  Mth Pneumo- 
cocci of Groups I  and IL 
Protection. 
Culture 
pneumococcus, 
Group I. 
Co. 
O.OI 
O.OOI 
o.oooI 
O.O000I 
0.000ooi 
Virulence controls. 
D.  I8 
,,  ,, 
"  20 
Antipneumococcus Serum I. 
Specific absorption 
with Pneumo- 
coccus I, 
D.  I8 
"  2o 
"  24 
"  48 
Non-specific 
absorption with 
PneumococcusII. 
S. 
Control. 
Serum unabsorbed. 
S. 
II 
~6 
Tables XII and XIII demonstrate the specificity of the absorption 
reaction with pneumococci of the fixed Types I and II.  Saturating 
an immune serum of Group I  with pneumococcus of the same type 
completely exhausts fhat serum of all its agglutinins and protective 
antibodies,  while absorption of  the same serum  with organisms  of 
Group II does not appreciably diminish these immune substances for 
pneumococci of Group I. Oswald  T.  Avery.  815 
Absorption  of Antipneumococcus  Serum  II with Pneumococcus  II  and  Organ- 
isms of Its Subgroups II A, II B, a~zd II X. 
Technique.--To  IO  cc.  of  undiluted  Antipneumococcus Serum  II  was  added 
the  washed  bacterial  residue  from  15o  cc.  of  an  eighteen  hour  broth  culture 
of  the  given  strain  of  pneumococcus.  Before  being  added  to  the  serum  the 
bacteria  were  killed  by  heating  at  560  C.  for  forty-five minutes.  The  serum 
mixtures were incubated in the water bath  for two hours at 37 °  C.  and  allowed 
to  remain in contact over night in the ice box.  The clumps of agglutinated bac- 
teria  were  whirled  out  by  centrifugation, and  the  clear  supernatant  serum  was 
pipetted  off.  This  serum  was  absorbed  a  second  time  by  the  same  technique, 
tested for the absence of agglutinins, and  called exhausted serum. 
TABLE  XIV. 
Cross-Agglutlnation  Reactions  u~th  Antipneumococcus  Serur~ II Exhausted  by 
Absorption  with  Type  Strains  of Pneumococcus  II  and  Its  Subgroups 
II A, II B, and II X. 
Antipneumococcus Serum II. 
Absorbed by 
Subgroup A, Jn 
"  B,  W 
"  X, S 13 
Group II 
Pneumococcus, 
Subgroup II A.  Subgroup II B.  Subgroup II X.  i Group II. 
i  .......  7~--  --T--[  TypelI.  Jn  I As  g  ]  M  W  !  Ar  I  J  S i 3 :FEB:  H 
....  ++  ++ 
+++++++_+1-  -  -P++  +  ++  ++ 
++++++++++++++  -  +  ++  ++ 
Table  XIV  shows  that  specific  absorption  of  Antipneumococcus 
Serum  II  With  the  typical  Type  II  pneumococcus  removes  all  the 
agglutinins, not only for the homologous organism, but also all the 
partial agglutinins for its subgroups, II A, II B, and II X.  In other 
words, specific absorption of Antipneumococcus Serum II completely 
exhausts it of both major and minor agglutinins.  Conversely, how- 
ever,  absorption  of  the same  immune  serum  with  a  representative 
strain of Subgroup II A  removes the minor agglutinins for members 
of that subgroup only, leaving intact the antibodies  for the Type II 
pneumococcus and its other  subgroups,  II  B  and II  X.  Similarly, 
absorption of Antipneumococcus Serum II with any member of Sub- 
group II  B  takes out the agglutinins for all the  Subgroup II  B  or- 
ganisms, 'but leaves  unaffected the antibodies  for the Type II pneu- 
mococcus  and  its  subgroups,  II  A  and  II  X.  The  lack  of  cross- 
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Subgroup  II  X  already  noted  in  the  previous  agglutination  and 
protective experiments  (Tables VI and X)  is  again  evident in the 
absorption tests.  Saturation of Immune Serum II with a pneumo- 
coccus of Subgroup II X  robs the serum of its agglutinins for that 
individual strain  only, and  for no  other. 
The results obtained by absorption experiments with Antipneumo- 
coccus  Serum II,  a  serum produced by  intensive immunization of 
the horse with a  single strain of the typical Type II pneumococcus, 
corroborate  the same  specific groupings obtained by  the  cross-im- 
munological reactions of agglutination and protection with immune 
rabbit sera of the individual strains. 
DISCUSSION. 
The biologic classification of the pneumococcus distinguishes four 
distinct groups.  These types are based upon well defined immuno- 
logic differences.  The accuracy  with  which these group.s  may be 
differentiated and the constancy of their relative frequence in disease 
and health emphasize the importance of their recognition in clinical 
and  epidemiological studies.  The  exactness  with  which the  large 
number of strains studied have conformed to type indicates the ex- 
traordinary uniformity and comparative fixity of the specific groups. 
These distinctive differences in antigenic properties not only offer a 
reliable method for the more exact determination of the varieties of 
pneumococcus, but  afford the  only rational basis  for the study of 
immunotherapy in pneumococcal infection. 
The second group  of  pneumococci of  the  original  classification 
consists of highly virulent organisms which are responsible for about 
one-third of all cases of lobar pneumonia of pneumoeoccus origin. 
Organisms  of  this  group  produce  infections  which  are  clinically 
severe, and the mortality of which is about 35 per cent.  The sero- 
logical reactions by means of which Group II was originally identi- 
fied are sharply defined.  So characteristic and prompt is the agglu- 
tination of any strain  of this type in Antipneumococcus Serum II 
that any deviation from the normal reaction is  quickly recognized. 
The isolation of an occasional strain of pneumococcus which agglu- 
tinates atypically in Antipneumocoecus Serum II led to an attempt to 
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type pneumococcus of Group II.  Of the ten strains studied five were 
isolated from disease and five  from the sputum of normal individ- 
uals.  T.hese organisms all exhibited the usual cul.tural and biochem- 
ical characteristics of the pneumococcus  ; namely, inulin fermentation, 
bile solubility, and varying degrees of capsular development.  The 
facts developed by this study indicate the existence of pneumococci 
which are biologically similar and closely allied to the typical organ- 
ism of Group II.  These organisms possess partial antigenic char- 
acters common to the Type II pneumococcus, but they vary from the 
typical representative of this  group by a  diversity of relationships 
among themselves, and by a lack of the reversibilityof their immune 
reactions with the type organism.  Because of these variations these 
organisms may be classified as subvar~ieties of Pneumococcus Group 
II.  All strains of the three subgroups thus far recognized are ag- 
glutinated by Antipneumococcus Serum  II,  but  the diminished in- 
tensity of the  reaction serves  to  distinguish them  from  typical  I1 
pneumococci.  The  incomplete reaction  of  agglutination  of  these 
subvarieties in the immune serum of Type II is apparently similar to 
fhe  diminished reactions  which  occur  in  many  immune sera  with 
other  organisms  closely allied  to  the  type  used  in  producing the 
serum.  Such reactions occur only in the higher concentrations of 
immune sera  and may be attributed  to  the so called minor agglu- 
tinins.  In such cases, also, a non-reversibility of the immune reac- 
tion has been noted.  For instance, a potent typhoid immune serum 
may agglutinate Bacillus  coli  in  the  higher concentrations, but an 
anticolon serum may not affect Bacillus  typhosus.  All  strains  of 
these  subgroups  of  pneumoeocci are  partially  agglutinated  in  the 
higher  concentrations of  Antipneumocoeeus Serum  II,  while  con- 
versely the immune serum produced by any strain of these subgroups 
fails to react with the typical II pneumococcus. 
In addition to the partial  agglutination of these strains  in Anti- 
pneumococcus Serum II and the absence of reverse immunity reac- 
tions, these subvarieties are  further characterized  by certain  inter- 
relationships of a definite antigenic nature, by virtue of which they 
may  be  classified  into  at  least  three  subgroups,  which  have  been 
called Subgroups II A, II B,  and II X.  It has been shown in the 
preceding protocols that a given member of either Subgroup II A or 818  Biologic  Classification  of Pneumococci. 
IIB is characterized by the possession of immunity reactions identi- 
cal with those of all other strains of the homologous subgroup, and 
that these reactions are specific only within the group.  Subgroup 
II X  is peculiar in that it seems to consist of a heterogeneous series 
of independent strains  which do not cross  in their  immunity reac- 
tions with members of the other two subgroups or with each other. 
This subgroup, like its prototype, Group IV, of the original biologic 
classification, is of lower virulence, infinitely variable in its composi- 
tion, and lacking in cross-immunity reactions.  As  has been noted, 
serum Type II  fails to protect against organisms of this subgroup, 
and inasnmch as specific protection is  regarded as  the ultimate cri- 
terion  for  classification,  it  is  doubtful whether organisms of  Sub- 
group II X are of sufficiently close relationship to be included within 
Group II. 
The specificity of these subgroups, II A and II B, as tested by the 
immunity reactions of agglutination and protection is  further con- 
firmed by the phenomenon of absorption.  Saturation of Antipneu- 
mococcus Serum II with a  typical Group II pneumococcus removes 
all  the  agglutinins both  for  the  type  organism  and  its  three  sub- 
groups.  Absorption of the same serum, however, with a  member 
of either Subgroup II A or IIB removes only the partial agglutinins 
for the homologous subgroup, but leaves intact the antibodies for the 
typical  II  pneumococcus and  the  other  subgroup.  Absorption  of 
Antipneumococcus Serum  II,  on the  other  hand,  by  any  member 
of Subgroup II X  takes out the antibodies for that particular strain 
only, and for no other. 
In the present discussion no attempt is made to interpret the ex- 
perimental  data  in  terms  of  their  phylogenetic  significance. 
Whe[her the subvarieties of the second group of pneumococci repre- 
sent strains which have acquired independently certain adaptive char- 
acters,  or whether they are  related to  each other and to  the fixed 
type  by  the  lineage  of  common descent is  interesting.  However, 
the  limited nature  of  the  present study precludes  the  formulation 
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SUMMARY. 
I.  At least three subgroups of Pneumococcus Type II may be rec- 
ognized by specific immune reactions.  T' ~v have been called Sub- 
groups II A, II B, and II X. 
2.  That  the organisms  of these three subgroups  are biologically 
related to Pneumococcus Type II is shown by the following facts: 
(a)  Agglutination  with  Antipneumococcus  Serum  II.  (b)  Pro- 
tection  with Antipneumococcus Serum  II,  except  Subgroup  II  X. 
(c) Absorption of Antipncumococcus Serum II with typical Type II 
pneumococcus removes the antibodies  for all subgroups.  (d)  Ab- 
sorption  of  Antipneumococcus Serum  II  with  a  member  of  Sub- 
groups II A or IIB removes only the antibodies for the homologous 
subgroup.  Absorption  of  Antipneumococcus  Serum  II  with  any 
given member of  Subgroup  II  X  removes the antibodies  for that 
particular strain only. 
3.  That the three subgroups, although biologically related to Pneu- 
mococcus Type  II,  possess,  nevertheless,  specific  differential  char- 
acters which separate them one  from another,  is  evidenced by the 
following facts : (a)  The organisms of any subgroup are not agglu- 
tinated by the antisera of the other two subgroups.  (b)  They are 
not protected against by the sera of the other subgroups.  (c)  They 
do not absorb from Antipneumococcus Serum II the specific immune 
bodies of the other subgroups. 
4-  Subgroups II A  and IIB are characterized by immunity reac- 
tions  identical within  the  respective  group. 
5.  Subgroup II X  consists of heterogeneous strains which do not 
cross in their immunity reaction with each other or with Subgroups 
II A or II B. 
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